Search research articles
Contact Us
Filters
Showing results (51-60 of 84) with videos related to
Page
of 9
Sort By:
Epilepsia
|
November 12, 2024
Cannabinoid-like compounds found in non-cannabis plants exhibit antiseizure activity in genetic mouse models of drug-resistant epilepsy
Ka Lai Yip, Michael Udoh, Laura A Sharman, et al.
ACS Chemical Neuroscience
|
September 13, 2019
Do Toxic Synthetic Cannabinoid Receptor Agonists Have Signature in Vitro Activity Profiles? A Case Study of AMB-FUBINACA
David B Finlay, Jamie J Manning, Mikkel Søes Ibsen, et al.
ACS Chemical Neuroscience
|
November 30, 2020
Synthesis and <i>in Vitro</i> Cannabinoid Receptor 1 Activity of Recently Detected Synthetic Cannabinoids 4F-MDMB-BICA, 5F-MPP-PICA, MMB-4en-PICA, CUMYL-CBMICA, ADB-BINACA, APP-BINACA, 4F-MDMB-BINACA, MDMB-4en-PINACA, A-CHMINACA, 5F-AB-P7AICA, 5F-MDMB-P7AICA, and 5F-AP7AICA
Annelies Cannaert, Eric Sparkes, Edward Pike, et al.
European Journal of Medicinal Chemistry
|
March 1, 2015
Ether analogues of DPA-714 with subnanomolar affinity for the translocator protein (TSPO)
Samuel D Banister, Corinne Beinat, Shane M Wilkinson, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 14, 2012
Consequences of linker length alteration of the α7 nicotinic acetylcholine receptor (nAChR) agonist, SEN12333
Corinne Beinat, Samuel D Banister, Saundra van Prehn, et al.
ACS Chemical Neuroscience
|
July 16, 2016
Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues
Samuel D Banister, Mitchell Longworth, Richard Kevin, et al.
Drug Testing and Analysis
|
October 10, 2019
Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography-tandem mass spectrometry - A New Zealand perspective of use in 2018
Rui Shen Ong, Diana C Kappatos, Sarah G G Russell, et al.
Organic & Biomolecular Chemistry
|
October 8, 2016
A systematic exploration of the effects of flexibility and basicity on sigma (σ) receptor binding in a series of substituted diamines
Trent Conroy, Madhura Manohar, Yu Gong, et al.
Drug Testing and Analysis
|
January 20, 2018
The chemistry and pharmacology of synthetic cannabinoid SDB-006 and its regioisomeric fluorinated and methoxylated analogs
Samuel D Banister, Alexander Olson, Matthew Winchester, et al.
Drug Testing and Analysis
|
March 31, 2021
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB<sub>1</sub> receptor activation assays: Part I-Synthesis, analytical characterization, and binding affinity for human CB<sub>1</sub> receptors
Edward Pike, Katharina Elisabeth Grafinger, Annelies Cannaert, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 84) with videos related to
Sort By:
Page
of 9
Epilepsia
|
November 12, 2024
Cannabinoid-like compounds found in non-cannabis plants exhibit antiseizure activity in genetic mouse models of drug-resistant epilepsy
Ka Lai Yip, Michael Udoh, Laura A Sharman, et al.
ACS Chemical Neuroscience
|
September 13, 2019
Do Toxic Synthetic Cannabinoid Receptor Agonists Have Signature in Vitro Activity Profiles? A Case Study of AMB-FUBINACA
David B Finlay, Jamie J Manning, Mikkel Søes Ibsen, et al.
ACS Chemical Neuroscience
|
November 30, 2020
Synthesis and <i>in Vitro</i> Cannabinoid Receptor 1 Activity of Recently Detected Synthetic Cannabinoids 4F-MDMB-BICA, 5F-MPP-PICA, MMB-4en-PICA, CUMYL-CBMICA, ADB-BINACA, APP-BINACA, 4F-MDMB-BINACA, MDMB-4en-PINACA, A-CHMINACA, 5F-AB-P7AICA, 5F-MDMB-P7AICA, and 5F-AP7AICA
Annelies Cannaert, Eric Sparkes, Edward Pike, et al.
European Journal of Medicinal Chemistry
|
March 1, 2015
Ether analogues of DPA-714 with subnanomolar affinity for the translocator protein (TSPO)
Samuel D Banister, Corinne Beinat, Shane M Wilkinson, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 14, 2012
Consequences of linker length alteration of the α7 nicotinic acetylcholine receptor (nAChR) agonist, SEN12333
Corinne Beinat, Samuel D Banister, Saundra van Prehn, et al.
ACS Chemical Neuroscience
|
July 16, 2016
Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues
Samuel D Banister, Mitchell Longworth, Richard Kevin, et al.
Drug Testing and Analysis
|
October 10, 2019
Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography-tandem mass spectrometry - A New Zealand perspective of use in 2018
Rui Shen Ong, Diana C Kappatos, Sarah G G Russell, et al.
Organic & Biomolecular Chemistry
|
October 8, 2016
A systematic exploration of the effects of flexibility and basicity on sigma (σ) receptor binding in a series of substituted diamines
Trent Conroy, Madhura Manohar, Yu Gong, et al.
Drug Testing and Analysis
|
January 20, 2018
The chemistry and pharmacology of synthetic cannabinoid SDB-006 and its regioisomeric fluorinated and methoxylated analogs
Samuel D Banister, Alexander Olson, Matthew Winchester, et al.
Drug Testing and Analysis
|
March 31, 2021
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB<sub>1</sub> receptor activation assays: Part I-Synthesis, analytical characterization, and binding affinity for human CB<sub>1</sub> receptors
Edward Pike, Katharina Elisabeth Grafinger, Annelies Cannaert, et al.
Page
of 9